United States Hospital Acquired Infections Market to Grow at 3.8% CAGR, Reaching USD 19.5 billion by 2030, Led by 3M, BD, and Johnson & Johnson | DataM Intelligence

The global hospital acquired infections market reached US$ 14.4 billion in 2022 and is expected to reach US$ 19.5 billion by 2030, growing at a CAGR of 3.8% during the forecast period 2023-2030, according to DataM Intelligence.

United States: Recent Industry Developments

✅ In October 2025, 3M Company launched a new antimicrobial surface coating proven to reduce HAIs by 65% in clinical trials.
✅ In September 2025, The Centers for Disease Control and Prevention allocated USD 1.2 billion for HAI prevention programs in U.S. hospitals.
✅ In August 2025, BD (Becton, Dickinson and Company) introduced a smart catheter with real-time infection monitoring capabilities.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/hospital-acquired-infections-market?jd

Europe: Recent Industry Developments

✅ In October 2025, Johnson & Johnson deployed an AI-powered surveillance system for early detection of surgical site infections across European hospitals.
✅ In September 2025, The European Centre for Disease Prevention and Control mandated enhanced HAI reporting standards across all EU member states.
✅ In August 2025, Getinge AB developed a novel sterilization system achieving 99.9999% efficacy against multi-drug resistant organisms.

Asia-Pacific: Recent Industry Developments

✅ In October 2025, Terumo Corporation launched a comprehensive HAI prevention bundle for Asian healthcare facilities.
✅ In September 2025, China's National Health Commission implemented strict HAI reduction targets for all Class III hospitals.
✅ In August 2025, Drägerwerk AG introduced a connected hand hygiene monitoring system reducing healthcare-associated infections by 45%.

Market Trends & Drivers

The United States Hospital Acquired Infections Market is experiencing robust growth driven by increasing surgical procedures, rising antimicrobial resistance, and stringent government regulations for infection control. Key trends include the development of advanced sterilization technologies, integration of IoT in infection surveillance, and advancement in antimicrobial coatings. The growing focus on patient safety, rising healthcare expenditures, and technological innovations in diagnostic and prevention methods are significantly accelerating market expansion.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/hospital-acquired-infections-market?jd

Competitive Landscape

The market features intense competition among medical device companies, infection control specialists, and healthcare solution providers.

1. 3M Company leads in infection prevention with comprehensive solutions including sterilization monitors and surgical drapes.
2. BD (Becton, Dickinson and Company) dominates in safety-engineered devices and diagnostic systems for infection control.
3. Johnson & Johnson provides extensive surgical care and infection prevention products through its Ethicon division.
4. Getinge AB specializes in sterilization equipment and infection control solutions for healthcare facilities.
5. STERIS plc offers comprehensive infection prevention technologies and services.
6. Cantel Medical Corp. provides water purification and disinfection systems for healthcare settings.
7. Belimed AG (Metall Zug Group) focuses on sterilization and disinfection equipment.
8. Stryker Corporation develops surgical instruments and infection prevention solutions.
9. Kimberly-Clark Corporation offers surgical gowns, drapes, and infection control products.
10. Terumo Corporation provides vascular access devices with enhanced safety features.

Buy now and enjoy a 30% year-end discount - limited-time offer! https://www.datamintelligence.com/buy-now-page?report=hospital-acquired-infections-market?jd
(Purchase 2 or more Reports and get 50% Discount)

Segmentation

By Infection Type (Gastrointestinal Infections, Ventilator Associated Pneumonia, Urinary Tract Infections, Surgical Site Infections, Bloodstream Infections, Others)
By Drug Type (Antibacterial Drug, Antiviral Drug, Antifungal Drug, Others)
By End User (Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers, Others)
By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (Germany, U.K., France, Italy, Spain, Netherlands, Rest of Europe)
⇥ Asia-Pacific (China, Japan, India, South Korea, Australia, Rest of Asia Pacific)
⇥ South America (Brazil, Argentina, Chile, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?jd

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us:
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com, Leander TX 78641

About Us:
DataM Intelligence is a market research and consulting firm that bridges the gap between data and decisive action. We specialize in translating top market trends and in-depth analysis into swift, smart solutions for your business.
With a repository of 6,300+ reports across 40+ industries, we provide the robust intelligence that over 200 companies in 50+ countries rely on to power their growth.

This release was published on openPR.